Results 211 to 220 of about 42,053 (270)
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]
, 2019 Cuculich, Phillip, et al,
core +1 more source
Radiofrequency ablation using the ThermoCool SmartTouch Catheter guided by ablation index versus antiarrhythmic drugs in atrial fibrillation treatment in China: a cost-consequence analysis. [PDF]
J Comp Eff ResZhang B +13 more
europepmc +1 more source
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population. [PDF]
Pharmacoecon OpenMoss JWE +17 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Cardiovascular Medicine, 2006
The use of antiarrhythmic drugs can be challenging to physicians. They are effective in treating various types of arrhythmias, yet their potential to cause adverse events, in particularly proarrhythmia, can be intimidating. When the decision to use antiarrhythmic therapy has been made, physicians are confronted with several issues: choosing the right ...
Brian R, Triola, Peter R, Kowey
openaire +2 more sources
The use of antiarrhythmic drugs can be challenging to physicians. They are effective in treating various types of arrhythmias, yet their potential to cause adverse events, in particularly proarrhythmia, can be intimidating. When the decision to use antiarrhythmic therapy has been made, physicians are confronted with several issues: choosing the right ...
Brian R, Triola, Peter R, Kowey
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2004
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Antiarrhythmic Drug Monitoring
Clinics in Laboratory Medicine, 1981The classification of antiarrhythmic agents by mechanism of action aids the clinician in selecting appropriate antiarrhythmic drug therapy. The pharmacokinetics, the side effects, and the interpretation of serum levels of quinidine, procainamide, disopyramide, lidocaine, and other agents are discussed.
J H, Howanitz, P J, Howanitz
openaire +2 more sources